Swedish registry data highlights important distinctions in warm autoimmune hemolytic anemia presentations. See how this rare condition differs when occurring as a primary disorder versus developing secondary to other health challenges:. #PLSP #Hematology

New study highlights interim ECHELON-3 study results comparing novel combination approaches for relapsed/refractory DLBCL. Discover how an antibody-drug conjugate plus immunomodulatory therapy performs against standard treatment:. #PLSP #Hematology

The EZTEAM study found ceftazidime-avibactam effective against antibiotic-resistant bacteria and it is mainly used as a second line of treatment for these infections. #PlainLanguageSummary

New study examines a TRK inhibitor's performance in patients with NTRK fusion-positive metastatic lung cancer. Discover how this targeted therapy demonstrated efficacy in this genetically-defined patient population:. #PLSP #ThoriacicOnco #GenomicMedicine

Adherence to prescribed medication in people with multiple sclerosis is linked to better outcomes and lower healthcare costs in the long term, while nonadherence has a significant negative impact on disease worsening and economic outcomes. #PLSP

New research analyzes the ELEVATE-RR and ASCEND trials comparing a second-generation BTK inhibitor against both standard chemotherapy and other targeted therapies for previously treated CLL/SLL. Discover the comparative effectiveness data: . #PLSP

A groundbreaking treatment approach for Alagille syndrome documented in new research. Learn how this targeted therapy addresses the debilitating pruritus that significantly impacts quality of life in patients with limited previous options:. #PLSP

Adherence to prescribed medication in people with multiple sclerosis is linked to better outcomes and lower healthcare costs in the long term, while nonadherence has a significant negative impact on disease worsening and economic outcomes. #PLSP

Advanced melanoma with brain involvement presents significant treatment challenges, addressed in new POLARIS study findings. Explore how optimized BRAF/MEK inhibition may improve outcomes for patients with limited options: . #PLSP #Melanoma

Medical records of 118 adults with diffuse large B-cell lymphoma reveal important insights about post-CAR-T treatment options. See how a novel CD19-targeting therapy performs when used at different points in the treatment journey:. #PLSP

The REAL-HLH study reveals real-world outcomes using an interferon-gamma inhibitor in U.S. patients with hemophagocytic lymphohistiocytosis. Learn how this targeted therapy addresses the dangerous immune overactivation in rheumatologic HLH cases:. #PLSP

A new study examines the benefits of oral prostanoid therapy when added to existing pulmonary arterial hypertension (PAH) treatments. Learn how this combination strategy helped slow disease progression and reduce hospitalizations in PAH. #PLSP

A comprehensive study of warm autoimmune hemolytic anemia (wAIHA) in Swedish patients reveals important insights. Learn how researchers differentiated between isolated wAIHA and cases occurring alongside other serious health conditions:. #PLSP #Hematology

The ongoing ECHELON-3 trial reveals promising data for patients with difficult-to-treat diffuse large B-cell lymphoma. Learn how this innovative three-drug regimen compares to the control arm in this important comparative study:. #PLSP #HematologicOncology

Webinar: Patient Authorship Guidelines.📅30th July | 3PM BST.🔗 Register: Discover how patient voices strengthen medical research! Join us to explore best practices & ethics in patient contributions to scientific publications. #PLSP #PatientAuthorship.

The EZTEAM study found ceftazidime-avibactam effective against antibiotic-resistant bacteria and it is mainly used as a second line of treatment for these infections. #PlainLanguageSummary

The latest research documents response rates for a targeted therapy in NTRK gene fusion-positive lung cancer. Explore how this precision medicine approach addresses a specific genetic alteration driving tumor growth:. #PLSP #ThoriacicOnco #GenomicMedicine

Adherence to prescribed medication in people with multiple sclerosis is linked to better outcomes and lower healthcare costs in the long term, while nonadherence has a significant negative impact on disease worsening and economic outcomes. #PLSP

The landmark ELEVATE-RR and ASCEND studies reveal important outcomes for relapsed chronic lymphocytic leukemia patients. Learn how this selective BTK inhibitor performs against established treatment options in this comprehensive analysis:. #PLSP

Adherence to prescribed medication in people with multiple sclerosis is linked to better outcomes and lower healthcare costs in the long term, while nonadherence has a significant negative impact on disease worsening and economic outcomes. #PLSP